Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
37,64 € ↑0,08 (0,21%)
2026-05-28
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionVestmark Advisory Solutions, Inc.
Latest Disclosed Ownership63,233 shares
Latest Disclosed Value $ 2,036,735
Vestmark Advisory Solutions, Inc. reports 14.85% decrease in ownership of 12V / Veracyte, Inc.

On May 15, 2026 - Vestmark Advisory Solutions, Inc. filed a 13F-HR form disclosing ownership of 63,233 shares of Veracyte, Inc. (DE:12V) valued at $1,681,998 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 74,260 shares of Veracyte, Inc.. This represents a change in shares of -14.85% during the quarter. The current value of the position is $2,380,090 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERACYTE COM 92337F107 63,233 -11,027 -14.85 2,037 -34.87 0.0140
2026-02-06 2025-12-31 13F VERACYTE COM 92337F107 74,260 -14,988 -16.79 3,126 2.06 0.0422
2025-11-10 2025-09-30 13F VERACYTE COM 92337F107 89,248 -87,964 -49.64 3,064 -36.05 0.0584
2025-08-06 2025-06-30 13F VERACYTE COM 92337F107 177,212 81,007 84.20 4,790 67.95 0.0692
2025-05-13 2025-03-31 13F VERACYTE COM 92337F107 96,205 -41,162 -29.96 2,852 -40.22 0.0734
2025-02-06 2024-12-31 13F VERACYTE COM 92337F107 137,367 14,791 12.07 4,772 14.36 0.1643
2024-11-14 2024-09-30 13F VERACYTE COM 92337F107 122,576 -26,169 -17.59 4,172 29.44 0.1553
2024-08-12 2024-06-30 13F VERACYTE COM 92337F107 148,745 -51,457 -25.70 3,223 -27.34 0.1346
2024-05-15 2024-03-31 13F VERACYTE COM 92337F107 200,202 23,887 13.55 4,436 -8.54 0.1911
2024-02-06 2023-12-31 13F VERACYTE COM 92337F107 176,315 176,315 4,850 0.2464
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.